Johnson & Johnson: all 3,718 studies

Page 22 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy SubjectsCompletedNCT02770222Phase 1
• Project BLOOM Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use EvaluationCompletedNCT02767336Not applicable
• RELIEF Europe StudyTerminatedNCT02762487Not applicable
• A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy ParticipantsCompletedNCT02758392Phase 1
• Shockwave Coronary Lithoplasty StudyCompletedNCT02758379Not applicable
• A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult ParticipantsCompletedNCT02748967Phase 1
• Comparison of Two Dose Strengths of Selexipag in Healthy AdultsCompletedNCT02745860Phase 1
• Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaWithdrawnNCT02743546Phase 1
• An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During RamadanCompletedNCT02737657
• A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02737605Phase 1
• Study of Acetaminophen (ACM) in Post-operative Dental PainCompletedNCT02735122Phase 3
• Concerta (Methylphenidate) -To-Generic Switch StudyCompletedNCT02730572
• A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy AdultsCompletedNCT02729467Phase 1
• Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid ArthritisCompletedNCT02728934
• A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision ReconstructionActive, not recruitingNCT02724371Not applicable
• Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder CancerCompletedNCT02722538Phase 1
• Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder CancerCompletedNCT02720367Phase 1
• Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use EvaluationCompletedNCT02718703Not applicable
• Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT02715011Phase 1
• A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month FormulationCompletedNCT02713282Phase 3
• A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With AntipsychoticsCompletedNCT02712463
• REDUCER-I: An Observational Study of the Neovasc Reducer™ SystemActive, not recruitingNCT02710435
• A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or CholangiocarcinomaCompletedNCT02699606Phase 2
• A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute GastroenteritisTerminatedNCT02699385Phase 3
• A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male ParticipantsCompletedNCT02692677Phase 1
• Epidemiology of Treatment Resistant Depression in TaiwanCompletedNCT02691520
• An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in CanadaCompletedNCT02688075
• Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCompletedNCT02685020Phase 1
• Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug UsersCompletedNCT02682225Phase 1
• Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy SubjectsCompletedNCT02675023Phase 1
• A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male ParticipantsCompletedNCT02674295Phase 1
• A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial VirusCompletedNCT02673476Phase 2
• A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced CancerTerminatedNCT02671955Phase 1
• A Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy ParticipantsCompletedNCT02670395Phase 1
• Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing CohortCompletedNCT02668991
• Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityCompletedNCT02663193
• A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
• A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922CompletedNCT02661893Phase 1
• Efficacy and Safety of Two Simeticone Brands in Adults With Functional DyspepsiaCompletedNCT02660372Phase 3
• A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet FormulationCompletedNCT02659735Phase 1
• A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy ParticipantsCompletedNCT02658825Phase 1
• Observational Patient Registry of the Dynamic Locking ScrewsWithdrawnNCT02656628
• A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and NorethindroneCompletedNCT02652650Phase 1
• A Study in a Human Laboratory Model of Smoking BehaviorCompletedNCT02641028Phase 2
• A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy AdultsCompletedNCT02638116Phase 1
• Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic AgentsCompletedNCT02636192
• Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneCompletedNCT02634463Phase 1
• A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic ArthritisCompletedNCT02627768
• Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate CancerCompletedNCT02625857Phase 1
• Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy ParticipantsCompletedNCT02623491Phase 1
• A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy ParticipantsCompletedNCT02617810Phase 1
• Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy ParticipantsCompletedNCT02617758Phase 1
• A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy ParticipantsCompletedNCT02611518Phase 1
• A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineCompletedNCT02611505Phase 1
• A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT02609789Phase 1
• Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung CancerActive, not recruitingNCT02609776Phase 1
• A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate CancerWithdrawnNCT02608359
• A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy ParticipantsCompletedNCT02608320Phase 1
• A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineCompletedNCT02606084Phase 1
• Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)CompletedNCT02600741
• An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV InfectionCompletedNCT02597270
• A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy ParticipantsCompletedNCT02595268Phase 1
• A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) InfectionTerminatedNCT02593851Phase 1
• Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung CancerTerminatedNCT02592967Phase 1
• A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate CancerActive, not recruitingNCT02592317Phase 1
• A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge StudyCompletedNCT02588521Phase 1
• A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyCompletedNCT02578797Phase 1
• A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy ParticipantsCompletedNCT02578550Phase 1
• Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy ParticipantsCompletedNCT02578472Phase 1
• Sedasys Post Approval Study Users Response to System AlarmsTerminatedNCT02573818
• A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy ParticipantsCompletedNCT02570373Phase 1
• Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy ParticipantsCompletedNCT02568176Phase 1
• Identification for the Treatment of Complex ArrhythmiasCompletedNCT02565069Not applicable
• Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral TabletCompletedNCT02561936Phase 1
• A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy ParticipantsCompletedNCT02561923Phase 1
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult VolunteersCompletedNCT02561871Phase 1
• Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin AmericaCompletedNCT02559583
• A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT02556892Phase 1
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male ParticipantsCompletedNCT02555124Phase 1
• A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860CompletedNCT02546960Phase 2
• A Registry of Participants With Prostate Cancer in AsiaCompletedNCT02546908
• A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult ParticipantsCompletedNCT02543567Phase 3
• A Study to Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult ParticipantsCompletedNCT02543268Phase 3
• Pilot Clinical Evaluation of Approved Contact LensesCompletedNCT02540122Phase 1
• Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone PalmitateCompletedNCT02532842
• An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASActive, not recruitingNCT02531516Phase 3
• A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male ParticipantsCompletedNCT02530060Phase 4
• A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic FunctionCompletedNCT02524717Phase 1
• A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT02519452Phase 1
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153TerminatedNCT02517359Phase 1
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male ParticipantsCompletedNCT02515955Phase 1
• A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy VolunteersCompletedNCT02512562Phase 1
• Heart Failure (HF) Interatrial Shunt Study 1WithdrawnNCT02511912Not applicable
• First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis CTerminatedNCT02510248Phase 1
• A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's DiseaseCompletedNCT02505568Phase 3
• Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter FeatureCompletedNCT02498054Not applicable
• A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT02497378Phase 1
• A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesActive, not recruitingNCT02494986Phase 2
• Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokersCompletedNCT02490358
• Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)CompletedNCT02489305

← Johnson & Johnson overview and focus areas